Alkermes (ALKS) Reports Q3 Loss of $0.11, Raises FY12 Guidance
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $49.06 --0%
Financial Fact:
Basic and diluted: -95.48M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Basic and diluted: -95.48M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q3 EPS of ($0.11), $0.10 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $125.6 million versus the consensus estimate of $113.94 million.
Alkermes sees FY2012 EPS of $-0.71-$-0.61, versus prior guidance of $-0.89-$-0.78 and the consensus of $-0.74. Alkermes sees FY2012 revenue of $370-$400 million, versus prior guidance of $350-$380 million and the consensus of $369.91 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Alkermes sees FY2012 EPS of $-0.71-$-0.61, versus prior guidance of $-0.89-$-0.78 and the consensus of $-0.74. Alkermes sees FY2012 revenue of $370-$400 million, versus prior guidance of $350-$380 million and the consensus of $369.91 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
- Genco rejects Diana Shipping bid, calls offer below NAV
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
